MIRA Pharmaceuticals, Inc.
MIRA
$1.44
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -13.87% | -29.57% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.82% | -14.35% | |||
| Operating Income | 14.82% | 14.35% | |||
| Income Before Tax | 26.01% | 13.80% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 26.01% | 13.80% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.01% | 13.80% | |||
| EBIT | 14.82% | 14.35% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -1,200.99% | 15.58% | |||
| Normalized Basic EPS | 24.73% | 15.52% | |||
| EPS Diluted | -1,200.99% | 15.58% | |||
| Normalized Diluted EPS | 24.73% | 15.52% | |||
| Average Basic Shares Outstanding | 13.47% | 2.05% | |||
| Average Diluted Shares Outstanding | 13.47% | 2.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||